Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monotherapy trials: presurgical studies.

G Pledger1

  • 1RW Johnson Pharmaceutical Research Institute, 929 Route 202, South Raritan, NJ 9202, USA. gpledger@prius.jnj.com

Epilepsy Research
|July 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A pooled analysis of adjunctive topiramate in refractory partial epilepsy.

Acta neurologica Scandinavica·2003
Same author

A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.

Neurology·2003
Same author

Childhood deaths from acute appendicitis in England and Wales 1963-97: observational population based study.

BMJ (Clinical research ed.)·2001
Same author

Proof of efficacy trials: choosing the dose.

Epilepsy research·2001
Same author

A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.

Epilepsia·2000
Same author

Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults.

Epilepsia·2000
Same journal

Effect of immunotherapy on seizure severity and spike-wave index in epileptic encephalopathy with spike-wave activation in sleep: The value of EEG spikes in monitoring treatment response.

Epilepsy research·2026
Same journal

Genetic heterogeneity, movement disorders, and white matter abnormalities in pediatric developmental and epileptic encephalopathies: A retrospective cohort study from a National Neurodegenerative and Leukodystrophy Registry.

Epilepsy research·2026
Same journal

Comment on "Predictors of surgical outcome in frontal lobe epilepsy: Experience from a single-center cohort in Latin America".

Epilepsy research·2026
Same journal

Response to: "A critical appraisal of principal component analysis of antiseizure medication-induced hostility/aggression and factor analysis of levetiracetam".

Epilepsy research·2026
Same journal

Access to inpatient video-EEG monitoring for patients with frequent seizure-related emergency visits.

Epilepsy research·2026
Same journal

Effect of the ketogenic diet on absence seizures in rats with genetic absence epilepsy.

Epilepsy research·2026
See all related articles

Presurgical evaluations for refractory epilepsy offer a unique chance for placebo-controlled trials. These studies assess antiepileptic drug (AED) efficacy but may not predict long-term clinical usefulness.

Area of Science:

  • Neurology
  • Clinical Pharmacology

Background:

  • Refractory partial seizures necessitate specialized treatment strategies.
  • Presurgical evaluation provides a unique setting for controlled antiepileptic drug (AED) trials.
  • Tapering AEDs is often required to induce seizures for evaluation.

Purpose of the Study:

  • To evaluate the feasibility and validity of placebo-controlled, monotherapy trials in the presurgical setting.
  • To assess the short-term efficacy of AEDs in patients with refractory epilepsy.
  • To fulfill regulatory requirements for AED approval.

Main Methods:

  • Conducting placebo-controlled, monotherapy trials during presurgical evaluation.
  • Tapering all existing antiepileptic drugs (AEDs) to induce seizures.
  • Continuous EEG monitoring throughout the trial period.

Related Experiment Videos

  • Randomizing patients refractory to previous treatments.

    • Main Results:

    • Presurgical trials demonstrate statistically significant differences between active AEDs and placebo in short-term therapy.
    • Studies using felbamate, gabapentin, and oxcarbazepine have been conducted in this setting.
    • The methodology supports the feasibility of evaluating AEDs in this specific patient population.

    Conclusions:

    • Presurgical placebo-controlled trials are valuable for elucidating short-term AED activity and meeting regulatory standards.
    • Short-term efficacy measures in presurgical trials may not accurately predict long-term clinical usefulness.
    • Patients in these trials can receive study drugs post-blinded period, ensuring potential therapeutic benefit.